RMD vs TPST · P/E 29, rev $5.65B vs $26.3M cap
ResMed Inc (RMD) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
TPST does not have a complete income-statement cache yet.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. TPST currently screens at market cap $26.3M.
Not investment advice. Open the RMD and TPST stock pages for the full models.
Not investment advice.